glp 1 pen tirzepatida Tirzepatide (Zepbound) for weight loss Lilly launches lower-price weight-loss drug

Whilst there is a range of possibilities that would require large-scale investigation, the authors also hypothesize that these discrepancies arise as women are less likely to have insulin abnormalities and are less susceptible to its detrimental effects

Rare side effects are hypoglycemia, pancreatitis, diabetic retinopathy, gall bladder problems, gastroparesis (due to slowed gastric emptying), and increased risk of aspiration during sedation and anesthesia

Both have similar side effect profiles (GI issues primarily), but individual responses vary

The Commonwealth Fund

Prevention focuses on slowing weight loss moderately, staying well-hydrated, eating regular small meals, and avoiding prolonged fasting